FindTrial
Sign In

Recovery from anaesthesia in mucormycosis patients

Recovery from anaesthesia in post-COVID mucormycosis debridement surgery: An observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037653
Enrollment
72
Registered
2021-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B338- Other specified viral diseases

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL

Sponsors

Roopa Sachidananda
Lead Sponsor
Madhuri S Kurdi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients who underwent post covid mucormycosis debridement surgery under general anesthesia

Exclusion criteria

Exclusion criteria: debridement surgery for non-covid mucormycosis, or mucormycosis due to post transplant immunosuppression, uraemia, burns, malnutrition, malignancy and chemotherapy, pregnant and paediatric patients

Design outcomes

Primary

MeasureTime frame
recovery from anaesthesia extubation timeTimepoint: upto 24 hours—

Secondary

MeasureTime frame
recovery from anaesthesia- extubation timeTimepoint: 48 hours—

Countries

India

Contacts

Public ContactRoopa Sachidananda

KIMS Hubli

roopasac@gmail.com9448658220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026